论文部分内容阅读
本文的目的是探讨肝功能减退、粘稠物阻塞症和某些其它疾病并发感染患者氟喹诺酮类(FQNs)的药动学特点,以利于提高疗效和减少不良反应.
The purpose of this paper is to investigate the pharmacokinetic characteristics of fluoroquinolones (FQNs) in patients with hepatic dysfunction, viscous obstruction and certain other diseases in order to improve efficacy and reduce adverse reactions.